O60500 (NPHN_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 122.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Nephrin Alternative name(s): Renal glomerulus-specific cell adhesion receptor | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 1241 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Seems to play a role in the development or function of the kidney glomerular filtration barrier. Regulates glomerular vascular permeability. May anchor the podocyte slit diaphragm to the actin cytoskeleton. Plays a role in skeletal muscle formation through regulation of myoblast fusion By similarity. |
| Subunit structure | Interacts with CD2AP (via C-terminal domain). Interacts with MAGI1 (via PDZ 2 and 3 domains) forming a tripartite complex with IGSF5/JAM4. Interacts with DDN; the interaction is direct. Self-associates (via the Ig-like domains). Also interacts (via the Ig-like domains) with KIRREL/NEPH1 and KIRREL2; the interaction with KIRREL is dependent on KIRREL glycosylation. Forms a complex with ACTN4, CASK, IQGAP1, MAGI2, SPTAN1 and SPTBN1 By similarity. Interacts with NPHS2. Ref.7 |
| Subcellular location | Cell membrane; Single-pass type I membrane protein Potential. Note: Predominantly located at podocyte slit diaphragm between podocyte foot processes. Also associated with podocyte apical plasma membrane. Ref.5 Ref.6 |
| Tissue specificity | Specifically expressed in podocytes of kidney glomeruli. |
| Developmental stage | In 23-week-old embryo found in epithelial podocytes of the periphery of mature and developing glomeruli. |
| Post-translational modification | Phosphorylated at Tyr-1193 by FYN, leading to the recruitment and activation of phospholipase C-gamma-1/PLCG1 By similarity. |
| Involvement in disease | Nephrotic syndrome 1 (NPHS1) [MIM:256300]: A renal disease characterized clinically by proteinuria, hypoalbuminemia, hyperlipidemia, and edema. Kidney biopsies show non-specific histologic changes such as focal segmental glomerulosclerosis and diffuse mesangial proliferation. Some affected individuals have an inherited steroid-resistant form and progress to end-stage renal failure. |
| Sequence similarities | Belongs to the immunoglobulin superfamily. Contains 1 fibronectin type-III domain. Contains 8 Ig-like C2-type (immunoglobulin-like) domains. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| NCK1 | P16333 | 3 | EBI-996920,EBI-389883 |
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: O60500-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: O60500-2) Also known as: Alpha; The sequence of this isoform differs from the canonical sequence as follows: 1056-1095: Missing. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||
Molecule processing | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 22 | 22 | Potential | ||||||||
| Chain | 23 – 1241 | 1219 | Nephrin | PRO_0000015052 | |||||||
Regions | |||||||||||
| Topological domain | 23 – 1055 | 1033 | Extracellular Potential | ||||||||
| Transmembrane | 1056 – 1076 | 21 | Helical; Potential | ||||||||
| Topological domain | 1077 – 1241 | 165 | Cytoplasmic Potential | ||||||||
| Domain | 27 – 130 | 104 | Ig-like C2-type 1 | ||||||||
| Domain | 143 – 234 | 92 | Ig-like C2-type 2 | ||||||||
| Domain | 242 – 333 | 92 | Ig-like C2-type 3 | ||||||||
| Domain | 340 – 434 | 95 | Ig-like C2-type 4 | ||||||||
| Domain | 440 – 540 | 101 | Ig-like C2-type 5 | ||||||||
| Domain | 544 – 635 | 92 | Ig-like C2-type 6 | ||||||||
| Domain | 740 – 832 | 93 | Ig-like C2-type 7 | ||||||||
| Domain | 838 – 939 | 102 | Ig-like C2-type 8 | ||||||||
| Domain | 941 – 1035 | 95 | Fibronectin type-III | ||||||||
| Region | 1160 – 1241 | 82 | Binds to NPHS2 | ||||||||
Amino acid modifications | |||||||||||
| Modified residue | 432 | 1 | Phosphoserine Ref.8 | ||||||||
| Modified residue | 1193 | 1 | Phosphotyrosine; by FYN By similarity | ||||||||
| Glycosylation | 40 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 356 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 401 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 547 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 553 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 564 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 577 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 680 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 708 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 908 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Disulfide bond | 53 ↔ 111 | Potential | |||||||||
| Disulfide bond | 160 ↔ 217 | Potential | |||||||||
| Disulfide bond | 265 ↔ 317 | Potential | |||||||||
| Disulfide bond | 361 ↔ 417 | Potential | |||||||||
| Disulfide bond | 465 ↔ 528 | Potential | |||||||||
| Disulfide bond | 567 ↔ 623 | Potential | |||||||||
| Disulfide bond | 761 ↔ 816 | Potential | |||||||||
| Disulfide bond | 863 ↔ 920 | Potential | |||||||||
Natural variations | |||||||||||
| Alternative sequence | 1056 – 1095 | 40 | Missing in isoform 2. | VSP_002598 | |||||||
| Natural variant | 64 | 1 | W → S in NPHS1; lack of protein expression on the cell surface. Ref.9 Ref.11 Ref.12 | VAR_013029 | |||||||
| Natural variant | 96 | 1 | L → V in NPHS1. Ref.14 | VAR_064194 | |||||||
| Natural variant | 107 | 1 | A → T in NPHS1. Ref.14 | VAR_064195 | |||||||
| Natural variant | 107 | 1 | A → V in NPHS1. Ref.16 | VAR_064196 | |||||||
| Natural variant | 117 | 1 | E → K. Ref.2 Ref.9 Ref.12 Ref.17 Corresponds to variant rs3814995 [ dbSNP | Ensembl ]. | VAR_013030 | |||||||
| Natural variant | 167 | 1 | P → L in NPHS1. Ref.16 | VAR_064197 | |||||||
| Natural variant | 171 | 1 | I → N in NPHS1; lack of protein expression on the cell surface. Ref.9 Ref.11 Ref.12 | VAR_013031 | |||||||
| Natural variant | 172 | 1 | Missing in NPHS1. Ref.9 Ref.12 Ref.16 | VAR_013032 | |||||||
| Natural variant | 173 | 1 | I → N in NPHS1; lack of protein expression on the cell surface. Ref.9 Ref.11 Ref.12 | VAR_013033 | |||||||
| Natural variant | 205 – 207 | 3 | TPR → I in NPHS1. | VAR_013034 | |||||||
| Natural variant | 233 | 1 | T → A. Corresponds to variant rs35238405 [ dbSNP | Ensembl ]. | VAR_049970 | |||||||
| Natural variant | 256 | 1 | R → W in NPHS1. Ref.15 | VAR_064198 | |||||||
| Natural variant | 264 | 1 | P → R Found in patients with nephrotic syndrome; unknown pathological significance. Ref.12 | VAR_064199 | |||||||
| Natural variant | 265 | 1 | C → R in NPHS1. Ref.13 | VAR_064200 | |||||||
| Natural variant | 270 | 1 | G → C in NPHS1; lack of protein expression on the cell surface. Ref.9 Ref.11 Ref.12 | VAR_013035 | |||||||
| Natural variant | 299 | 1 | R → C in NPHS1. Ref.16 | VAR_064201 | |||||||
| Natural variant | 340 | 1 | P → H in NPHS1. Ref.16 | VAR_064202 | |||||||
| Natural variant | 347 | 1 | G → E in NPHS1. Ref.16 | VAR_064203 | |||||||
| Natural variant | 350 | 1 | S → P in NPHS1; lack of protein expression on the cell surface. Ref.9 Ref.11 Ref.12 Ref.16 | VAR_013036 | |||||||
| Natural variant | 366 | 1 | S → R in NPHS1; lack of protein expression on the cell surface; the mutant protein is retained in the endoplasmic reticulum. Ref.9 Ref.11 Ref.12 Ref.16 | VAR_013037 | |||||||
| Natural variant | 367 | 1 | R → C in NPHS1; lack of protein expression on the cell surface. Ref.9 Ref.11 Ref.12 Ref.15 Ref.16 | VAR_013038 | |||||||
| Natural variant | 368 | 1 | P → L in NPHS1. Ref.12 | VAR_064204 | |||||||
| Natural variant | 368 | 1 | P → S in NPHS1; lack of protein expression on the cell surface. Ref.9 Ref.11 Ref.12 | VAR_013039 | |||||||
| Natural variant | 376 | 1 | L → V in NPHS1; does not affect protein expression on the cell surface. Ref.9 Ref.11 Ref.12 | VAR_013040 | |||||||
| Natural variant | 379 | 1 | R → W in NPHS1. Ref.12 | VAR_064205 | |||||||
| Natural variant | 392 | 1 | L → P. Corresponds to variant rs34320609 [ dbSNP | Ensembl ]. | VAR_049971 | |||||||
| Natural variant | 407 | 1 | R → W in NPHS1. Ref.16 | VAR_064206 | |||||||
| Natural variant | 408 | 1 | R → Q in NPHS1; uncertain pathological significance; does not affect protein expression on the cell surface. Ref.9 Ref.11 Ref.12 Ref.16 Corresponds to variant rs33950747 [ dbSNP | Ensembl ]. | VAR_013041 | |||||||
| Natural variant | 412 | 1 | G → C in NPHS1. Ref.15 | VAR_064207 | |||||||
| Natural variant | 417 | 1 | C → F in NPHS1. Ref.12 | VAR_064208 | |||||||
| Natural variant | 447 | 1 | E → K. Ref.10 Ref.12 Corresponds to variant rs28939695 [ dbSNP | Ensembl ]. | VAR_013042 | |||||||
| Natural variant | 460 | 1 | R → Q in NPHS1. Ref.12 Ref.14 Ref.16 | VAR_064209 | |||||||
| Natural variant | 465 | 1 | C → Y in NPHS1; lack of protein expression on the cell surface. Ref.9 Ref.11 Ref.12 | VAR_013043 | |||||||
| Natural variant | 519 | 1 | P → S in NPHS1. Ref.15 | VAR_064210 | |||||||
| Natural variant | 528 | 1 | C → F in NPHS1; lack of protein expression on the cell surface. Ref.9 Ref.11 Ref.12 | VAR_013044 | |||||||
| Natural variant | 558 | 1 | R → C in NPHS1. Ref.12 Ref.16 | VAR_064211 | |||||||
| Natural variant | 569 | 1 | S → R in NPHS1. Ref.15 | VAR_064212 | |||||||
| Natural variant | 572 | 1 | S → N in NPHS1. Ref.16 | VAR_064213 | |||||||
| Natural variant | 575 | 1 | P → Q in NPHS1. Ref.14 | VAR_064214 | |||||||
| Natural variant | 586 | 1 | R → G in NPHS1. Ref.16 | VAR_064215 | |||||||
| Natural variant | 587 | 1 | L → R in NPHS1. Ref.16 | VAR_064216 | |||||||
| Natural variant | 610 | 1 | L → Q in NPHS1; lack of protein expression on the cell surface. Ref.9 Ref.11 Ref.12 | VAR_013045 | |||||||
| Natural variant | 617 | 1 | H → R Found in patients with nephrotic syndrome; unknown pathological significance. Ref.12 | VAR_064217 | |||||||
| Natural variant | 623 | 1 | C → F in NPHS1; lack of protein expression on the cell surface. Ref.9 Ref.11 Ref.12 Ref.16 | VAR_013046 | |||||||
| Natural variant | 673 | 1 | N → K in NPHS1. Ref.16 | VAR_064218 | |||||||
| Natural variant | 681 | 1 | W → C in NPHS1. Ref.16 | VAR_064219 | |||||||
| Natural variant | 709 | 1 | V → G in NPHS1. Ref.15 | VAR_064220 | |||||||
| Natural variant | 724 | 1 | S → C in NPHS1; does not affect protein expression on the cell surface. Ref.9 Ref.11 Ref.12 | VAR_013047 | |||||||
| Natural variant | 725 | 1 | E → D Found in patients with nephrotic syndrome; unknown pathological significance. Ref.12 | VAR_064221 | |||||||
| Natural variant | 739 | 1 | A → V in NPHS1. Ref.12 | VAR_064222 | |||||||
| Natural variant | 742 | 1 | I → T in NPHS1. Ref.17 | VAR_067252 | |||||||
| Natural variant | 743 | 1 | R → C in NPHS1; does not affect protein expression on the cell surface. Ref.9 Ref.11 Ref.12 Ref.16 | VAR_013048 | |||||||
| Natural variant | 802 | 1 | R → P in NPHS1; lack of protein expression on the cell surface. Ref.9 Ref.11 Ref.12 | VAR_013050 | |||||||
| Natural variant | 802 | 1 | R → W in NPHS1; lack of protein expression on the cell surface. Ref.9 Ref.11 Ref.12 | VAR_013049 | |||||||
| Natural variant | 806 | 1 | A → D in NPHS1; lack of protein expression on the cell surface. Ref.9 Ref.11 Ref.12 | VAR_013051 | |||||||
| Natural variant | 819 | 1 | D → V in NPHS1. Ref.10 Ref.12 | VAR_013052 | |||||||
| Natural variant | 822 | 1 | V → M in NPHS1. Ref.13 | VAR_064223 | |||||||
| Natural variant | 831 | 1 | R → C in NPHS1; lack of protein expression on the cell surface. Ref.9 Ref.11 | VAR_013053 | |||||||
| Natural variant | 832 | 1 | L → P in NPHS1; the mutant protein is retained in the endoplasmic reticulum. Ref.14 | VAR_064224 | |||||||
| Natural variant | 834 | 1 | V → F in NPHS1. Ref.12 | VAR_064225 | |||||||
| Natural variant | 851 | 1 | A → V Found in patients with nephrotic syndrome; unknown pathological significance. Ref.12 | VAR_064226 | |||||||
| Natural variant | 910 | 1 | S → P in NPHS1. Ref.16 | VAR_064227 | |||||||
| Natural variant | 976 | 1 | R → S in NPHS1. Ref.14 Ref.16 | VAR_064228 | |||||||
| Natural variant | 991 | 1 | V → L. Corresponds to variant rs34736717 [ dbSNP | Ensembl ]. | VAR_049972 | |||||||
| Natural variant | 1077 | 1 | N → S. Ref.9 Ref.12 Corresponds to variant rs4806213 [ dbSNP | Ensembl ]. | VAR_013054 | |||||||
| Natural variant | 1140 | 1 | R → C in NPHS1; does not affect protein expression on the cell surface. Ref.9 Ref.11 Ref.16 | VAR_013055 | |||||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Positionally cloned gene for a novel glomerular protein -- nephrin --is mutated in congenital nephrotic syndrome." Kestilae M., Lenkkeri U., Maennikkoe M., Lamerdin J.E., McCready P., Putaala H., Ruotsalainen V., Morita T., Nissinen M., Herva R., Kashtan C.E., Peltonen L., Holmberg C., Olsen A., Tryggvason K. Mol. Cell 1:575-582(1998) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), INVOLVEMENT IN NPHS1. |
| [2] | "Novel human pathological mutations. Gene symbol: NPHS1. Disease: congenital nephrotic syndrome, Finnish type." Tikhomirov E., Voznesenskaya T., Tsygin A. Hum. Genet. 125:334-334(2009) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANT LYS-117. |
| [3] | "Human nephrin (NPHS1) cDNA sequence." Grunkemeyer J.A., Kumar N., Kalluri R. Submitted (SEP-1999) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). |
| [4] | "The DNA sequence and biology of human chromosome 19." Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S., Carrano A.V. Lucas S.M.Nature 428:529-535(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [5] | "Nephrin localizes at the podocyte filtration slit area and is characteristically spliced in the human kidney." Holthoefer H., Ahola H., Solin M.-L., Wang S.-X., Palmen T., Luimula P., Miettinen A., Kerjaschki D. Am. J. Pathol. 155:1681-1687(1999) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 1032-1134 (ISOFORM 2), SUBCELLULAR LOCATION. |
| [6] | "Nephrin is specifically located at the slit diaphragm of glomerular podocytes." Ruotsalainen V., Ljungberg P., Wartiovaara J., Lenkkeri U., Kestilae M., Jalanko H., Holmberg C., Tryggvason K. Proc. Natl. Acad. Sci. U.S.A. 96:7962-7967(1999) [PubMed] [Europe PMC] [Abstract] Cited for: SUBCELLULAR LOCATION. |
| [7] | "Interaction with podocin facilitates nephrin signaling." Huber T.B., Kottgen M., Schilling B., Walz G., Benzing T. J. Biol. Chem. 276:41543-41546(2001) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH NPHS2. |
| [8] | "Phosphoproteome of resting human platelets." Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J., Schuetz C., Walter U., Gambaryan S., Sickmann A. J. Proteome Res. 7:526-534(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-432, MASS SPECTROMETRY. Tissue: Platelet. |
| [9] | "Structure of the gene for congenital nephrotic syndrome of the Finnish type (NPHS1) and characterization of mutations." Lenkkeri U., Maennikkoe M., McCready P., Lamerdin J., Gribouval O., Niaudet P.M., Antignac C.K., Kashtan C.E., Homberg C., Olsen A., Kestilae M., Tryggvason K. Am. J. Hum. Genet. 64:51-61(1999) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS LYS-117 AND SER-1077, VARIANTS NPHS1 SER-64; ASN-171; THR-172 DEL; ASN-173; 205-THR--ARG-207 DELINS ILE; CYS-270; PRO-350; ARG-366; CYS-367; SER-368; VAL-376; GLN-408; TYR-465; PHE-528; GLN-610; PHE-623; CYS-724; CYS-743; TRP-802; PRO-802; ASP-806; CYS-831 AND CYS-1140. |
| [10] | "Novel mutation in the nephrin gene of a Japanese patient with congenital nephrotic syndrome of the Finnish type." Aya K., Tanaka H., Seino Y. Kidney Int. 57:401-404(2000) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT NPHS1 VAL-819, VARIANT LYS-447. |
| [11] | "Defective nephrin trafficking caused by missense mutations in the NPHS1 gene: insight into the mechanisms of congenital nephrotic syndrome." Liu L., Done S.C., Khoshnoodi J., Bertorello A., Wartiovaara J., Berggren P.O., Tryggvason K. Hum. Mol. Genet. 10:2637-2644(2001) [PubMed] [Europe PMC] [Abstract] Cited for: CHARACTERIZATION OF VARIANTS NPHS1 SER-64; ASN-171; ASN-173; CYS-270; PRO-350; ARG-366; CYS-367; SER-368; VAL-376; GLN-408; TYR-465; PHE-528; GLN-610; PHE-623; CYS-724; CYS-743; TRP-802; PRO-802; ASP-806; CYS-831 AND CYS-1140. |
| [12] | "Mutation spectrum in the nephrin gene (NPHS1) in congenital nephrotic syndrome." Beltcheva O., Martin P., Lenkkeri U., Tryggvason K. Hum. Mutat. 17:368-373(2001) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS NPHS1 SER-64; ASN-171; THR-172 DEL; ASN-173; CYS-270; PRO-350; ARG-366; CYS-367; LEU-368; SER-368; VAL-376; TRP-379; GLN-408; PHE-417; GLN-460; TYR-465; PHE-528; CYS-558; GLN-610; PHE-623; CYS-724; VAL-739; CYS-743; TRP-802; PRO-802; ASP-806; VAL-819 AND PHE-834, VARIANTS LYS-117; ARG-264; LYS-447; ARG-617; ASP-725; VAL-851 AND SER-1077. |
| [13] | "A familial childhood-onset relapsing nephrotic syndrome." Kitamura A., Tsukaguchi H., Hiramoto R., Shono A., Doi T., Kagami S., Iijima K. Kidney Int. 71:946-951(2007) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS NPHS1 ARG-265 AND MET-822. |
| [14] | "Nephrin mutations can cause childhood-onset steroid-resistant nephrotic syndrome." Philippe A., Nevo F., Esquivel E.L., Reklaityte D., Gribouval O., Tete M.J., Loirat C., Dantal J., Fischbach M., Pouteil-Noble C., Decramer S., Hoehne M., Benzing T., Charbit M., Niaudet P., Antignac C. J. Am. Soc. Nephrol. 19:1871-1878(2008) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS NPHS1 VAL-96; THR-107; GLN-460; GLN-575; PRO-832 AND SER-976, CHARACTERIZATION OF VARIANT NPHS1 PRO-832. |
| [15] | "Thirteen novel NPHS1 mutations in a large cohort of children with congenital nephrotic syndrome." Heeringa S.F., Vlangos C.N., Chernin G., Hinkes B., Gbadegesin R., Liu J., Hoskins B.E., Ozaltin F., Hildebrandt F. Nephrol. Dial. Transplant. 23:3527-3533(2008) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS NPHS1 TRP-256; CYS-367; CYS-412; SER-519; ARG-569 AND GLY-709. |
| [16] | "Nineteen novel NPHS1 mutations in a worldwide cohort of patients with congenital nephrotic syndrome (CNS)." Schoeb D.S., Chernin G., Heeringa S.F., Matejas V., Held S., Vega-Warner V., Bockenhauer D., Vlangos C.N., Moorani K.N., Neuhaus T.J., Kari J.A., MacDonald J., Saisawat P., Ashraf S., Ovunc B., Zenker M., Hildebrandt F. Nephrol. Dial. Transplant. 25:2970-2976(2010) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS NPHS1 VAL-107; LEU-167; THR-172 DEL; 205-THR--ARG-207 DELINS ILE; CYS-299; HIS-340; GLU-347; PRO-350; ARG-366; CYS-367; TRP-407; GLN-408; GLN-460; CYS-558; ASN-572; GLY-586; ARG-587; PHE-623; LYS-673; CYS-681; CYS-743; PRO-910; SER-976 AND CYS-1140. |
| [17] | "Two novel NPHS1 mutations in a Chinese family with congenital nephrotic syndrome." Wu L.Q., Hu J.J., Xue J.J., Liang D.S. Genet. Mol. Res. 10:2517-2522(2011) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT NPHS1 THR-742, VARIANT LYS-117. |
| + | Additional computationally mapped references. |
Web resources
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AF035835 mRNA. Translation: AAC39687.1. EU642886 mRNA. Translation: ACH99862.1. AF190637 mRNA. Translation: AAG17141.1. AC002133 Genomic DNA. No translation available. AF126957 mRNA. Translation: AAF36451.1. |
| IPI | IPI00219898. IPI00747010. |
| PIR | T37190. |
| RefSeq | NP_004637.1. NM_004646.3. |
| UniGene | Hs.122186. |
3D structure databases | |
| ProteinModelPortal | O60500. |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | O60500. 6 interactions. |
| STRING | 9606.ENSP00000368190. |
PTM databases | |
| PhosphoSite | O60500. |
Proteomic databases | |
| PaxDb | O60500. |
| PRIDE | O60500. |
Protocols and materials databases | |
| DNASU | 4868. |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000353632; ENSP00000343634; ENSG00000161270. ENST00000378910; ENSP00000368190; ENSG00000161270. |
| GeneID | 4868. |
| KEGG | hsa:4868. |
| UCSC | uc002oby.3. human. |
Organism-specific databases | |
| CTD | 4868. |
| GeneCards | GC19M036316. |
| HGNC | HGNC:7908. NPHS1. |
| HPA | CAB035555. |
| MIM | 256300. phenotype. 602716. gene. |
| neXtProt | NX_O60500. |
| Orphanet | 839. Congenital nephrotic syndrome, Finnish type. 93214. Familial idiopathic steroid-resistant nephrotic syndrome with diffuse mesangial proliferation. 93213. Familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis. 93216. Familial idiopathic steroid-resistant nephrotic syndrome with minimal changes. |
| PharmGKB | PA31709. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | NOG251936. |
| HOGENOM | HOG000113844. |
| HOVERGEN | HBG031752. |
| InParanoid | O60500. |
| OMA | ATLTWYK. |
Enzyme and pathway databases | |
| Reactome | REACT_111155. Cell-Cell communication. |
Gene expression databases | |
| Bgee | O60500. |
| CleanEx | HS_NPHS1. |
| Genevestigator | O60500. |
| GermOnline | ENSG00000161270. Homo sapiens. |
Family and domain databases | |
| Gene3D | 2.60.40.10. 10 hits. |
| InterPro | IPR013162. CD80_C2-set. IPR003961. Fibronectin_type3. IPR007110. Ig-like_dom. IPR013783. Ig-like_fold. IPR003599. Ig_sub. IPR003598. Ig_sub2. IPR013106. Ig_V-set. [Graphical view] |
| Pfam | PF08205. C2-set_2. 5 hits. PF00041. fn3. 1 hit. PF07686. V-set. 1 hit. [Graphical view] |
| SMART | SM00060. FN3. 1 hit. SM00409. IG. 5 hits. SM00408. IGc2. 1 hit. [Graphical view] |
| SUPFAM | SSF49265. FN_III-like. 1 hit. |
| PROSITE | PS50853. FN3. 1 hit. PS50835. IG_LIKE. 7 hits. [Graphical view] |
| ProtoNet | Search... |
Other | |
| GenomeRNAi | 4868. |
| NextBio | 18748. |
| SOURCE | Search... |
Entry information
| Entry name | NPHN_HUMAN | ||||||||
| Accession | Primary (citable) accession number: O60500 Secondary accession number(s): A6NDH2, C3RX61 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 19 Human chromosome 19: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
